Research output per year
Research output per year
Fingerprint
Dive into the research topics where Deborah Blumenthal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Collaborative privacy-preserving analysis of oncological data using multiparty homomorphic encryption
Geva, R., Gusev, A., Polyakov, Y., Liram, L., Rosolio, O., Alexandru, A., Genise, N., Blatt, M., Duchin, Z., Waissengrin, B., Mirelman, D., Bukstein, F., Blumenthal, D. T., Wolf, I., Pelles-Avraham, S., Schaffer, T., Lavi, L. A., Micciancio, D., Vaikuntanathan, V., Badawi, A. A., & 1 others, 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 33, e2304415120.Research output: Contribution to journal › Article › peer-review
Open Access -
Model-free dynamic contrast-enhanced MRI analysis: differentiation between active tumor and necrotic tissue in patients with glioblastoma
Bressler, I., Ben Bashat, D., Buchsweiler, Y., Aizenstein, O., Limon, D., Bokestein, F., Blumenthal, T. D., Nevo, U. & Artzi, M., Feb 2023, In: Magnetic Resonance Materials in Physics, Biology, and Medicine. 36, 1, p. 33-42 10 p.Research output: Contribution to journal › Article › peer-review
-
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Mellinghoff, I. K., Van Den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., Ducray, F., Umemura, Y., Nabors, B., Holdhoff, M., Hottinger, A. F., Arakawa, Y., Sepulveda, J. M., Wick, W., Soffietti, R., Perry, J. R., & 10 others, 2023, In: New England Journal of Medicine. 389, 7, p. 589-601 13 p.Research output: Contribution to journal › Article › peer-review
-
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide
Bota, D. A., Taylor, T. H., Lomeli, N., Kong, X. T., Fu, B. D., Schönthal, A. H., Singer, S., Blumenthal, D. T., Senecal, F. M., Linardou, H., Rokas, E., Antoniou, D. G., Schijns, V. E. J. C., Chen, T. C., Elliot, J. & Stathopoulos, A., 28 Jun 2022, In: Frontiers in Oncology. 12, 934638.Research output: Contribution to journal › Article › peer-review
Open Access -
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Das, A., Sudhaman, S., Morgenstern, D., Coblentz, A., Chung, J., Stone, S. C., Alsafwani, N., Liu, Z. A., Karsaneh, O. A. A., Soleimani, S., Ladany, H., Chen, D., Zatzman, M., Cabric, V., Nobre, L., Bianchi, V., Edwards, M., Sambira Nahum, L. C., Ercan, A. B., Nabbi, A., & 63 others, Jan 2022, In: Nature Medicine. 28, 1, p. 125-135 11 p.Research output: Contribution to journal › Article › peer-review
Open Access